Publications
Innovative Technologies in CNS Trials: Promises and Pitfalls for Recruitment, Retention, and Representativeness
Jacqueline Lutz, Abhishek Pratap, Eric J. Lenze, Durga Bestha, Jessica M. Lipschitz, Stella Karantzoulis, Uma Vaidyanathan, Jessica Robin, William Horan, Stephen Brannan, Aurelia Mittoux, Michael C. Davis, Shaheen E. Lakhan, Richard Keefe
Innovations in Clinical Neuroscience, 2023;20(7-9):40-46
Conducting CNS trials during a public health emergency – Lessons learned from the COVID-19 pandemic: A joint ISCTM/ECNP working group consensus paper
Kemi Olugemo, Dragana Bugarski-Kirola, Gerard R. Dawson, Franco DiCesare, Dejan Stevanovic, Janko Samardzic, Andreas Chatzittofis, Raeanne Moore, Joris C. Vester, Lais Bhering, Eduard Vieta
Neuroscience Applied, Volume 2, 2023, 101129
Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants
Christian Yavorsky, Elizabeth Ballard, Mark Opler, Jan Sedway, Steven D Targum, and William Lenderking for ISCTM Assessment Methods and Endpoints for Rapid-Acting Antidepressants-RAADs Working Group
Frontiers in Psychiatry, Volume 14 - 2023
Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder
Elena Polverejan, Michael O'Kelly, Nanco Hefting, Jonathan D Norton, Pilar Lim, Marc K Walton
Therapeutic Innovation & Regulatory Science (2023)
Remote Assessment of Negative Symptoms of Schizophrenia
David G Daniel, Alex S Cohen, Dawn Velligan, Phillip D Harvey, Larry Alphs, Michael Davidson, William Potter, Alan Kott, Nina Schooler, Christopher R Brodie, Raeanne C Moore, Pierre Lindenmeyer, Stephen R Marder
Schizophrenia Bulletin Open, Volume 4, Issue 1, January 2023
Patient Centricity: Design and Conduct of Clinical Trials in Orphan Diseases: Third of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug Development
Joan Busner, Gahan Pandina, Simon Day, Atul Mahableshwarkar, Lucas Kempf, Maria Sheean, Judith Dunn
Innovations in Clinical Neuroscience, 2023;20(1-3): 25-31
Implications of Pediatric Initiatives on CNS Drug Development for All Ages—2020 and Beyond: Second of Three Sets of Expanded Proceedings from the 2020 ISCTM Autumn Conference on Pediatric Drug Development
Gahan Pandina, Joan Busner, Joseph P. Horrigan, Christine McSherry, Alison Bateman-House, Luca Pani, Judith Kando
Innovations in Clinical Neuroscience, 2023;20(1-3): 18-24
Special Challenges in Pediatric Drug Development: First of Three Sets of Expanded Proceedings from the ISCTM Autumn Conference on Pediatric Drug Development
Philip D. Harvey, Joan Busner, Gahan Pandina, H. Gerry Taylor, Meg Grabb, Joohi Jimenez-Shahed
Innovations in Clinical Neuroscience, 2023; 20(1-3): 13-17
Consistency Checks to Improve Measurement with the Hamilton Rating Scale for Anxiety (HAM-A)
Jonathan Rabinowitz, Janet B W Williams, Nanco Hefting, Ariana Anderson, Brianne Brown, Dong Jing Fu, Bashkim Kadriu, Alan Kott, Atul Mahableshwarkar, Jan Sedway, David Williamson, Christian Yavorsky, Nina R Schooler
Journal of Affective Disorders, Vol. 325
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials
Erica A. Smith, William P. Horan, Dominique Demolle, Peter Schueler, Dong-Jing Fu, Ariana E. Anderson, Joseph Geraci, Florence Butlen-Ducuing, Jasmine Link, Ni A. Khin, Robert Morlock, Larry D. Alphs
Innovations in Clinical Neuroscience, 2022;19(1–3):60-70.